Introduction: The Silent Pandemic Crisis
Antimicrobial Resistance (AMR) has become one of the most serious challenges to global health today. This problem is even more concerning in India, where 297,000 deaths occurred directly due to antibiotic resistance in 2019. According to World Health Organization reports, 4.71 million deaths were linked to bacterial AMR globally in 2021, of which 1.14 million deaths were directly caused by AMR.
The Journey from Antibiotics to Resistance
At the beginning of the 20th century, antibiotics were called 'magic bullets' because they gave humanity the power to combat bacterial infections for the first time. However, today the situation has reversed. Antimicrobial Resistance (AMR) occurs when bacteria learn to defend themselves against drugs, making even common infections difficult to treat.
Current Status of AMR in India
According to National Centre for Disease Control (NCDC) data:
More than 70% of E. coli and at least 80% of Klebsiella pneumoniae in India are extended-spectrum beta-lactamase (ESBL) producers
Carbapenem resistance in E. coli increased from 19% to 34% between 2017-2022
Carbapenem resistance in Klebsiella pneumoniae increased from 41% to 58%
More than 90% of Acinetobacter baumannii are resistant to carbapenems
Main Causes of Rising AMR
1. Uncontrolled Drug Distribution
Easy availability of antibiotics without prescription
Weak regulatory and monitoring systems
2. Misconceptions and Misuse
People's misconception that antibiotics cure every disease
Use of antibiotics even for viral infections
3. Healthcare Infrastructure Deficits
Only 7.8% of patients in India receive appropriate antibiotics for carbapenem-resistant infections
Alarming Future Projections
The Lancet Predictions
Between 2025-2050, more than 39 million deaths could occur due to AMR. If immediate action is not taken:
Antibiotic use could increase by 20% by 2030 compared to 2016
Annual deaths could reach 2 million by 2050 - 70% more than 2021
India-Specific Data
Antibiotic use in low and middle-income countries has increased by 20-30%
India's South Asian region could become the region with the highest AMR mortality rate in 2050
Government of India Initiatives
National Action Plan (NAP-AMR)
India launched the National Action Plan on AMR in 2017 with 6 main priorities:
Improve education and awareness of AMR through effective communication, education, and training
Strengthen knowledge and evidence through surveillance
Reduce infection rates through effective infection prevention and control
Optimize the use of antimicrobial agents in the health sector
Promote investment in AMR activities
Strengthen international cooperation
NARS-Net Network
The National AMR Surveillance Network (NARS-Net) includes 60 state medical college laboratories across 27 states and 6 union territories as of June 2024.
Direction for Solutions
Impact of Better Healthcare
According to The Lancet study, better healthcare and antibiotic access could save 92 million lives between 2025-2050.
Economic Factors
Research shows that a ₹1000 increase in per capita GDP reduces private sector antibiotic use by 10.2 doses per 1000 people per year.
Why this matters for your exam preparation
For UPSC Main Examination:
GS Paper-2: Health, education, human resources development and management of social sector/services
GS Paper-3: Achievements of Indians in science and technology; indigenization of technology
Important Facts for Preliminary Examination:
NARS-Net establishment year: 2013
NAP-AMR launch year: 2017
India's WHO-GLASS membership: 2017
NCDC's central role in AMR: National coordination center
For Other Competitive Examinations:
State-level civil service examinations health policy questions
Banking examinations current affairs section
SSC general awareness
Possible questions from this topic: Questions based on carbapenem resistance, WHO priority pathogens, One Health approach, and India's National Action Plan may appear.
Stay connected with Atharva Examwise and get daily important current affairs updates for UPSC and other competitive examinations.
